Observational Prospective Study to Determine the Evolution of the Symptomatic Profile of Metastatic Non-Small Cell Lung Cancer (NSCLC) Patients and Its Relation to the Control of the Disease

ConclusionThe first-line treatment of NSCLC is correlated with an improvement in the symptomatic evolution of advanced NSCLC patients.FundingRoche.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research